Nutra Pharma Corp (NPHC) Operating Leases (2018 - 2025)

Nutra Pharma has disclosed Operating Leases across 8 years of filings, most recently posting $24056.0 for Q3 2025.

• In Q3 2025, Operating Leases fell 79.08% year-over-year to $24056.0; the TTM figure through Sep 2025 stood at $24056.0 (down 79.08% YoY), while the FY2024 annual figure was $93411.0, down 47.26% from the prior year.
• Operating Leases came in at $24056.0 for Q3 2025 at Nutra Pharma, down from $93411.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $251951.0 in Q4 2022 to a low of $20003.0 in Q3 2022.
• Average Operating Leases over 5 years is $121393.9, with a median of $113243.0 recorded in 2021.
• Year-over-year, Operating Leases sank 79.08% in 2022 and soared 881.78% in 2023.
• Over 5 years, Operating Leases stood at $77673.0 in 2021, then jumped by 224.37% to $251951.0 in 2022, then retreated by 29.7% to $177114.0 in 2023, then tumbled by 47.26% to $93411.0 in 2024, then slumped by 74.25% to $24056.0 in 2025.
• Per Business Quant data, the three most recent Operating Leases figures were $24056.0 in Q3 2025, $93411.0 in Q4 2024, and $114967.0 in Q3 2024.